Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

38.35
Delayed Data
As of Feb 16
 -0.80 / -2.04%
Today’s Change
24.65
Today|||52-Week Range
50.05
-3.76%
Year-to-Date
No recent news for Supernus Pharmaceuticals Inc.

Today’s Trading

Previous close39.15
Today’s open39.20
Day’s range37.85 - 39.80
Volume448,758
Average volume (3 months)545,002
Market cap$2.0B
Data as of 4:00pm ET, 02/16/2018

Growth & Valuation

Earnings growth (last year)+528.57%
Earnings growth (this year)-38.42%
Earnings growth (next 5 years)+27.00%
Revenue growth (last year)+48.87%
P/E ratio34.9
Price/Sales6.07
Price/Book9.99

Competitors

 Today’s
change
Today’s
% change
FOLDAmicus Therapeutics ...-0.66-4.17%
PRTAProthena Corporation...+1.09+3.39%
IRWDIronwood Pharmaceuti...-0.14-0.90%
HZNPHorizon Pharma PLC-0.20-1.42%
Data as of 4:00pm ET, 02/16/2018

Financials

Next reporting dateMarch 14, 2018
EPS forecast (this quarter)$0.28
Annual revenue (last year)$215.0M
Annual profit (last year)$91.2M
Net profit margin42.43%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, Secretary &
Director
Jack A. Khattar
Chief Financial Officer &
Vice President
Gregory S. Patrick
Corporate headquarters
Rockville, Maryland

Forecasts